SCHEMBL96728

SCHEMBL96728

O=[C]CCCC=CCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 1/20 0.57
MAOB P27338 1/20 0.56
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
ARG2 P78540 1/20 0.40
KCNH2 Q12809 2/20 0.36
EPHX2 P34913 5/20 0.34
FAAH O00519 3/20 0.34
CNR1 P21554 2/20 0.33
CNR2 P34972 2/20 0.33
MAPK1 P28482 1/20 0.32
GPR52 Q9Y2T5 2/20 0.32
SLCO2A1 Q92959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96727 1.00 TOP1 (0.57) TOP1MAOBCA1CA2ARG2
SCHEMBL97048 0.89 MAOB (0.60) TOP1MAOBCA1CA2ARG2
SCHEMBL97047 0.89 MAOB (0.60) TOP1MAOBCA1CA2ARG2
SCHEMBL97223 0.82 KCNH2 (0.41) TOP1MAOBKCNH2CNR1
SCHEMBL97222 0.82 KCNH2 (0.41) TOP1MAOBKCNH2CNR1
SCHEMBL96844 0.79 TOP1 (0.62) TOP1MAOBCA1CA2ARG2
SCHEMBL96845 0.79 TOP1 (0.62) TOP1MAOBCA1CA2ARG2
SCHEMBL5541407 0.77 TOP1 (0.53) TOP1MAOBCA1CA2ARG2
SCHEMBL5541411 0.77 TOP1 (0.53) TOP1MAOBCA1CA2ARG2
SCHEMBL96729 0.77 TOP1 (0.61) TOP1MAOBCA1CA2ARG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB TOP1 1468/4885MAOB 2043/4885CA1 3276/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 TOP1 3013/4885MAOB 4538/4885CA1 2592/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 TOP1 3013/4885MAOB 4538/4885CA1 2592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.